0,854  0,010  Apoptosis agonist
0,768  0,012  Antineoplastic (breast cancer)
0,753  0,017  Caspase 9 stimulant
0,745  0,013  Antineoplastic (lung cancer)
0,736  0,011  TNF expression inhibitor
0,746  0,023  Antiinflammatory
0,703  0,006  Cardiovascular analeptic
0,699  0,008  Sensitization
0,700  0,010  Prostate cancer treatment
0,684  0,010  Antineoplastic (ovarian cancer)
0,662  0,025  Transcription factor NF kappa B inhibitor
0,616  0,010  NOS2 expression inhibitor
0,612  0,010  Antineoplastic (pancreatic cancer)
0,622  0,021  Antileukemic
0,592  0,010  Nitric oxide antagonist
0,579  0,010  Antineoplastic (glioma)
0,585  0,025  Antineoplastic (colorectal cancer)
0,569  0,016  Antipruritic, allergic
0,576  0,024  Antineoplastic (colon cancer)
0,562  0,018  Immunosuppressant
0,546  0,006  Antineoplastic (liver cancer)
0,518  0,009  ICAM1 expression inhibitor
0,524  0,017  Caspase 3 stimulant
0,523  0,020  Antineoplastic (cervical cancer)
0,509  0,010  Antineoplastic (endocrine cancer)
0,520  0,030  Teratogen
0,480  0,007  Calcium channel activator
0,473  0,007  Contraceptive
0,458  0,009  Prostatic (benign) hyperplasia treatment
0,452  0,003  Contraceptive female
0,477  0,033  Embryotoxic
0,441  0,008  Prostate disorders treatment
0,490  0,059  Antineoplastic (solid tumors)
0,458  0,027  AR expression inhibitor
0,456  0,027  NOS3 expression inhibitor
0,440  0,011  UGT1A4 substrate
0,450  0,028  Antineoplastic (brain cancer)
0,466  0,044  CYP2C9 substrate
0,454  0,033  Antihypercholesterolemic
0,421  0,005  Neurotrophic factor enhancer
0,420  0,009  Antiacne
0,419  0,010  Interferon gamma antagonist
0,437  0,034  Hepatic disorders treatment
0,414  0,014  Abortion inducer
0,420  0,026  Chemopreventive
0,443  0,052  CYP3A4 substrate
0,398  0,010  Antipruritic, non-allergic
0,397  0,011  Hair growth stimulant
0,398  0,013  Diuretic
0,401  0,024  Antihypoxic
0,393  0,030  Proliferative diseases treatment
0,398  0,036  Cytotoxic
0,392  0,033  Antineoplastic (multiple myeloma)
0,367  0,009  Antiviral (Influenza A)
0,380  0,024  Sodium/bile acid cotransporter inhibitor
0,384  0,035  UGT2B4 substrate
0,365  0,015  UGT2B7 substrate
0,378  0,032  Antipyretic
0,387  0,043  Antineoplastic (melanoma)
0,389  0,046  Respiratory analeptic
0,367  0,030  Antiparasitic
0,346  0,010  Interleukin 6 antagonist
0,347  0,014  Lipocortins synthesis antagonist
0,348  0,019  Antiviral (Influenza)
0,367  0,039  Hypoxia-inducible factor 1 alpha inhibitor
0,350  0,023  Growth hormone agonist
0,353  0,032  Transcription factor STAT3 inhibitor
0,359  0,038  DNA damaging
0,355  0,034  Antineoplastic (renal cancer)
0,337  0,025  UGT1A1 substrate
0,329  0,018  Antineoplastic (squamous cell carcinoma)
0,341  0,031  Antineoplastic (lymphocytic leukemia)
0,341  0,038  Transcription factor STAT inhibitor
0,325  0,023  Hepatoprotectant
0,340  0,039  Carcinogenic
0,315  0,015  UGT2B15 substrate
0,329  0,030  UDP-glucuronosyltransferase substrate
0,306  0,011  Cholesterol synthesis inhibitor
0,319  0,024  Non-steroidal antiinflammatory agent
0,337  0,043  Renal disease treatment
0,318  0,028  Antihelmintic
0,329  0,040  Antineoplastic (glioblastoma multiforme)
0,305  0,016  Diabetic nephropathy treatment
0,317  0,032  Platelet aggregation inhibitor
0,323  0,042  Heart failure treatment
0,318  0,040  UGT1A6 substrate
0,331  0,058  Analeptic
0,329  0,056  CYP2C19 substrate
0,281  0,011  Antineoplastic antibiotic
0,277  0,013  Topoisomerase I inhibitor
0,276  0,013  Antifungal enhancer
0,270  0,009  Farnesoid X receptor antagonist
0,314  0,056  UGT1A9 substrate
0,261  0,004  Antineoplastic alkaloid
0,293  0,038  Gastrin inhibitor
0,303  0,048  Vascular (periferal) disease treatment
0,328  0,074  Bone diseases treatment
0,280  0,030  Antialcoholic
0,251  0,003  Aldosterone antagonist
0,298  0,052  Cardiodepressant
0,301  0,069  Antineoplastic (osteosarcoma)
0,310  0,079  Apoptosis antagonist
0,257  0,029  UGT1A3 substrate
0,237  0,009  Arachidonic acid antagonist
0,236  0,010  Androgen antagonist
0,290  0,065  Antioxidant
0,309  0,085  Cholesterol antagonist
0,318  0,098  Ulceration
0,286  0,073  Antiosteoporotic
0,294  0,083  Antifungal
0,230  0,020  UGT2B10 substrate
0,222  0,012  Menstruation disorders treatment
0,217  0,008  Actinic keratosis treatment
0,215  0,005  CDC25A inhibitor
0,232  0,026  UGT2B9 substrate
0,213  0,012  Antiinfertility, female
0,234  0,034  Antineoplastic (carcinoma)
0,215  0,017  Endometrios treatment
0,205  0,007  Interleukin 2 antagonist
0,268  0,072  Chemoprotective
0,247  0,052  Anesthetic general
0,226  0,031  Phospholipase A2 inhibitor
0,207  0,014  Growth stimulant
0,202  0,013  Adenylate cyclase stimulant
0,224  0,035  LDLR expression enhancer
0,253  0,066  Antineoplastic (lymphoma)
0,185  0,005  Bile acid receptor antagonist
0,254  0,076  Antineoplastic (non-small cell lung cancer)
0,251  0,074  Tumour necrosis factor alpha release inhibitor
0,300  0,124  Histamine release inhibitor
0,183  0,007  Anabolic
0,187  0,011  ABCA1 expression enhancer
0,264  0,089  Cardioprotectant
0,263  0,091  Immunostimulant
0,224  0,055  Pneumotoxic
0,257  0,089  GST M1-1 substrate
0,202  0,035  Phobic disorders treatment
0,175  0,009  Tocolytic
0,208  0,044  Antiviral (Herpes)
0,187  0,023  Microtubule formation inhibitor
0,194  0,032  Antinephritic
0,237  0,076  Angiogenesis stimulant
0,165  0,004  Na+ K+ transporting ATPase inhibitor
0,260  0,101  CYP2D6 substrate
0,227  0,068  Antiparkinsonian, rigidity relieving
0,158  0,006  Glycine receptor agonist
0,161  0,008  Ornithine decarboxylase inhibitor
0,162  0,012  Aromatase inhibitor
0,195  0,046  Toxic, respiratory center
0,159  0,012  Antiviral (SARS coronavirus)
0,159  0,012  Antiviral (Coronavirus)
0,192  0,045  Protein kinase stimulant
0,167  0,021  TRPA1 agonist
0,193  0,047  Antirickettsial
0,148  0,003  Heme oxygenase stimulant
0,158  0,013  Keratolytic
0,156  0,013  Paget's disease treatment
0,215  0,074  Antihypertriglyceridemic
0,206  0,067  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,162  0,024  HDL-cholesterol increasing
0,162  0,024  Antineoplastic, alkylator
0,171  0,033  Adenylate cyclase inhibitor
0,175  0,037  DNA polymerase I inhibitor
0,142  0,004  RNA-directed RNA polymerase stimulant
0,252  0,116  Interleukin 2 agonist
0,163  0,027  Choleretic
0,224  0,090  DNA synthesis inhibitor
0,147  0,017  Transcription factor NF kappa B stimulant
0,172  0,043  Acetylcholinesterase inhibitor
0,146  0,017  UGT2B11 substrate
0,135  0,007  Progesterone antagonist
0,136  0,008  Androgen agonist
0,140  0,012  Glutamate release inhibitor
0,162  0,039  Cyclooxygenase 3 inhibitor
0,218  0,095  Aldehyde oxidase inhibitor
0,155  0,035  Heat shock protein 70 antagonist
0,157  0,038  Autism spectrum disorders treatment
0,183  0,066  Antineoplastic (gastric cancer)
0,209  0,092  Cytostatic
0,231  0,116  CYP1A2 substrate
0,182  0,068  Sigma receptor agonist
0,128  0,014  Glycine receptor antagonist
0,236  0,124  CTGF expression inhibitor
0,166  0,056  Pulmonary hypertension treatment
0,152  0,042  DNA intercalator
0,218  0,110  Lipoprotein disorders treatment
0,152  0,045  Protein-tyrosine phosphatase 1B inhibitor
0,125  0,020  Contraceptive male
0,185  0,081  VEGF expression inhibitor
0,154  0,050  Antieczematic
0,118  0,015  Postmenopausal disorders treatment
0,151  0,051  Pregnane X receptor agonist
0,110  0,011  Uterine relaxant
0,163  0,064  Acaricide
0,141  0,043  Carcinogenic, group 2B
0,132  0,035  Dementia treatment
0,218  0,120  5 Hydroxytryptamine uptake stimulant
0,163  0,066  Melanin inhibitor
0,148  0,051  Retinoprotector
0,163  0,067  Protein-tyrosine phosphatase inhibitor
0,150  0,055  Carcinogenic, group 3
0,163  0,069  Antimutagenic
0,128  0,034  Vascular dementia treatment
0,145  0,053  Antihyperlipoproteinemic
0,207  0,115  5 Hydroxytryptamine release stimulant
0,136  0,044  Alcohol dehydrogenase substrate
0,206  0,115  Interleukin agonist
0,095  0,005  Adenylate cyclase 1 inhibitor
0,154  0,064  Genotoxic
0,113  0,023  3C-Like protease (SARS coronavirus) inhibitor
0,195  0,107  RNA-directed DNA polymerase inhibitor
0,231  0,143  Vasodilator, peripheral
0,095  0,007  Postcoital contraceptive
0,109  0,023  Lipase inhibitor
0,133  0,048  Glutathione S-transferase substrate
0,091  0,007  Acetyl-CoA transferase 2 inhibitor
0,127  0,043  Estrogen antagonist
0,298  0,215  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,184  0,102  Antineoplastic enhancer
0,170  0,088  Platelet adhesion inhibitor
0,275  0,195  5 Hydroxytryptamine release inhibitor
0,202  0,122  Antineoplastic (sarcoma)
0,087  0,010  Mineralocorticoid receptor antagonist
0,176  0,100  Insulin sensitizer
0,087  0,011  5-Alpha-reductase inhibitor
0,079  0,005  Estrone sulfatase inhibitor
0,117  0,043  GST T1-1 substrate
0,106  0,032  ATPase (Vacuolar H+) inhibitor
0,198  0,124  Radioprotector
0,150  0,077  Cholinergic
0,083  0,012  Lipocortins synthesis agonist
0,096  0,026  Cushing's syndrome treatment
0,191  0,121  Hypoglycemic
0,153  0,084  Mutagenic
0,076  0,008  Cholesterol esterase inhibitor
0,128  0,059  Beta amyloid protein antagonist
0,072  0,004  Cholesterol ester transfer protein antagonist
0,085  0,019  SULT2A1 substrate
0,239  0,173  15-Lipoxygenase inhibitor
0,085  0,021  Estrogen agonist
0,135  0,072  Psychosexual dysfunction treatment
0,139  0,076  Ca2+-transporting ATPase inhibitor
0,126  0,063  Alkylator
0,218  0,156  Antithrombotic
0,204  0,142  Antipsoriatic
0,145  0,083  Eye irritation, high
0,078  0,017  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,072  0,013  Anesthetic inhalation
0,136  0,077  Antiparkinsonian, tremor relieving
0,113  0,055  UGT2B1 substrate
0,067  0,009  Glucocorticoid antagonist
0,130  0,075  Amylase inhibitor
0,123  0,067  Antiviral (Hepatitis B)
0,112  0,056  AMP-activated protein kinase stimulant
0,107  0,052  Estrogen receptor beta antagonist
0,128  0,075  Anesthetic
0,185  0,134  Cardiotonic
0,076  0,026  Antimycoplasmal
0,128  0,078  CC chemokine 6 receptor antagonist
0,192  0,142  Flavin-containing monooxygenase substrate
0,088  0,038  Estrogen receptor alpha antagonist
0,059  0,010  Hypogonadism treatment
0,098  0,051  SULT1E1 substrate
0,114  0,068  Platelet activating factor antagonist
0,101  0,055  Lanosterol 14 alpha demethylase inhibitor
0,153  0,108  Antineoplastic (bone cancer)
0,110  0,065  Vasculitis treatment
0,050  0,004  Potassium channel (Inward rectifier) 1 blocker
0,118  0,073  Aldehyde dehydrogenase inhibitor
0,055  0,012  Alpha 1L adrenoreceptor agonist
0,055  0,012  Farnesoid X receptor agonist
0,056  0,014  Parathyroid hormone antagonist
0,046  0,006  Retinoid X gamma receptor agonist
0,153  0,113  P-glycoprotein inhibitor
0,127  0,087  Lipid peroxidase inhibitor
0,050  0,011  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,163  0,125  Hypolipemic
0,213  0,177  FMO1 substrate
0,045  0,009  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,049  0,015  Retinoic acid alpha receptor agonist
0,075  0,042  Dysmenorrhea treatment
0,230  0,197  Antibacterial
0,050  0,017  DNA gyrase subunit A inhibitor
0,208  0,178  GST A substrate
0,060  0,031  Pregnane X receptor antagonist
0,035  0,007  Retinoid X beta receptor agonist
0,099  0,073  Skin irritative effect
0,052  0,027  Potassium channel Kv1.3 blocker
0,057  0,032  Acetyl-CoA transferase inhibitor
0,033  0,008  Retinoid X gamma receptor antagonist
0,070  0,046  Premenstrual syndrome treatment
0,042  0,018  Glucose-6-phosphate dehydrogenase inhibitor
0,051  0,027  Microtubule stabilization
0,038  0,014  ATP citrate lysase inhibitor
0,165  0,142  VCAM1 expression inhibitor
0,035  0,012  Liver X receptor alpha antagonist
0,144  0,121  Psychostimulant
0,104  0,082  Topoisomerase II inhibitor
0,029  0,007  Progesterone agonist
0,115  0,094  Antihemorrhagic
0,028  0,007  Retinoic acid gamma receptor agonist
0,029  0,008  Corticosteroid-like
0,038  0,017  Tubulin agonist
0,086  0,066  Potassium channel activator
0,047  0,027  Nicotinic receptor alpha3 subunit antagonist
0,029  0,010  Retinoic acid receptor agonist
0,041  0,022  Retinoid X receptor agonist
0,068  0,050  Anticholelithogenic
0,026  0,008  Retinoic acid alpha receptor antagonist
0,042  0,024  Cholesterol absorption inhibitor
0,142  0,124  Interleukin antagonist
0,074  0,057  Nicotinic alpha4beta2 receptor antagonist
0,156  0,138  Antiprotozoal (Leishmania)
0,156  0,140  Antiamyloidogenic
0,059  0,043  Potassium channel intermediate-conductance Ca-activated blocker
0,022  0,006  Telomerase stimulant
0,138  0,123  ATPase inhibitor
0,023  0,009  Retinoic acid receptor antagonist
0,092  0,078  Expectorant
0,032  0,020  Liver X receptor antagonist
0,043  0,031  Heme oxygenase inhibitor
0,043  0,032  Geranyltranstransferase inhibitor
0,023  0,012  Inosine monophosphate dehydrogenase 1 inhibitor
0,035  0,024  Retinoid X alpha receptor agonist
0,096  0,085  GABA C receptor antagonist
0,023  0,014  GRP78 expression inhibitor
0,021  0,012  Retinoic acid beta receptor agonist
0,095  0,087  SULT1A1 substrate
0,140  0,132  Succinate dehydrogenase inhibitor
0,124  0,116  Muscle relaxant
0,063  0,056  Hypercalcemia treatment
0,022  0,015  Vitamin D receptor antagonist
0,021  0,014  Retinoid X beta receptor antagonist
0,017  0,011  Vitamin D receptor agonist
0,013  0,007  Retinoic acid receptor gamma antagonist
0,160  0,155  Antidiabetic symptomatic
0,013  0,008  Retinoic acid beta receptor antagonist
0,038  0,033  Liver X receptor alpha agonist
0,049  0,045  Nicotinic alpha3beta2 receptor antagonist
0,014  0,009  Glucocorticoid agonist
0,025  0,021  Complement factor 1r inhibitor
0,040  0,036  Liver X receptor agonist
0,057  0,054  Nitric oxide donor
0,012  0,010  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,026  0,024  Hedgehog signaling activator
0,041  0,039  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,056  0,054  Transcription factor AP-1 inhibitor
0,137  0,136  Phospholipase C inhibitor
0,111  0,110  Vanilloid 1 agonist
0,014  0,013  NMDA receptor phencyclidine site antagonist
0,036  0,036  Acetyl-CoA transferase 1 inhibitor
0,034  0,034  Retinoid X receptor antagonist

